Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR8 | P51685 | 8/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TOP2A | P11388 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ACP1 | P24666 | 1/20 | 0.35 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 4/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29264324 | 0.75 | CCR8 (0.45) | CCR8MEN1KMT2ATOP2AL3MBTL1 | |
| SCHEMBL30873752 | 0.74 | TACR1 (0.43) | NR1H2PARP1 | |
| SCHEMBL873237 | 0.73 | RAD52 (0.41) | NR1H2PARP1 | |
| SCHEMBL5333905 | 0.72 | HTR2C (0.47) | NR1H2NR1H3PARP1 | |
| SCHEMBL28019268 | 0.71 | HTR2C (0.44) | MEN1KMT2A | |
| SCHEMBL30502301 | 0.71 | HTR2C (0.44) | NR1H2PARP1 | |
| SCHEMBL29135380 | 0.71 | NR1H2 (0.38) | MEN1KMT2ANR1H2NR1H3PARP1 | |
| SCHEMBL31556646 | 0.70 | NR1H2 (0.53) | NR1H2NR1H3PARP1 | |
| SCHEMBL22285173 | 0.70 | NR1H2 (0.49) | NR1H2NR1H3PARP1 | |
| SCHEMBL874416 | 0.70 | NR1H2 (0.49) | NR1H2NR1H3PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118271284-A | Estrogen receptor modulators and uses thereof | 江苏威凯尔医药科技有限公司 | 2024-07-02 | — | — | CN | disclosed |